89Sr therapy for pain relief in patients with bone metastases

Kiyoshi Koizumi, Ali Syed Arbab, Keiji Toyama, Masayo Shirasu, Sachiko Osawa, Takuji Araki, Motoshi Yamaguchi, Hiroshi Onishi, Tsutomu Araki, Takao Arai, Hideki Komatsu, Akira Ueno, Hisashi Nokata

Research output: Contribution to journalArticle

Abstract

Radioactive strontium chloride ( 89Sr) was administered for pain relief in 6 patients with bone metastases (4 prostate cancer and 2 breast cancer patients). Out of 6 patients, 2 showed apparent relief of bone pain and improvement of QOL, and 3 showed slight relief of the pain with or without improvement of QOL; that is, 83% was effective. Side effects were seen in 2 patients; transient deterioration of bone pain in one patient and bone marrow suppression in the other patient. The patient who showed bone marrow suppression had rather more lesions of bone metastasis (diffuse metastasis) and least urinary excretion of the radioactivity. Urinary excretion for 2 days varied 5 to 40% of the administered dose and was less in the patients with more metastatic lesions.

Original languageEnglish (US)
Pages (from-to)1243-1248
Number of pages6
JournalKakuigaku
Volume33
Issue number11
StatePublished - Dec 1 1996
Externally publishedYes

Fingerprint

Neoplasm Metastasis
Bone and Bones
Pain
Therapeutics
Bone Marrow
Breast Neoplasms
Radioactivity
Prostatic Neoplasms

Keywords

  • Bone metastasis
  • Pain relief
  • Radionuclide therapy
  • Sr

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Koizumi, K., Arbab, A. S., Toyama, K., Shirasu, M., Osawa, S., Araki, T., ... Nokata, H. (1996). 89Sr therapy for pain relief in patients with bone metastases. Kakuigaku, 33(11), 1243-1248.

89Sr therapy for pain relief in patients with bone metastases. / Koizumi, Kiyoshi; Arbab, Ali Syed; Toyama, Keiji; Shirasu, Masayo; Osawa, Sachiko; Araki, Takuji; Yamaguchi, Motoshi; Onishi, Hiroshi; Araki, Tsutomu; Arai, Takao; Komatsu, Hideki; Ueno, Akira; Nokata, Hisashi.

In: Kakuigaku, Vol. 33, No. 11, 01.12.1996, p. 1243-1248.

Research output: Contribution to journalArticle

Koizumi, K, Arbab, AS, Toyama, K, Shirasu, M, Osawa, S, Araki, T, Yamaguchi, M, Onishi, H, Araki, T, Arai, T, Komatsu, H, Ueno, A & Nokata, H 1996, '89Sr therapy for pain relief in patients with bone metastases', Kakuigaku, vol. 33, no. 11, pp. 1243-1248.
Koizumi K, Arbab AS, Toyama K, Shirasu M, Osawa S, Araki T et al. 89Sr therapy for pain relief in patients with bone metastases. Kakuigaku. 1996 Dec 1;33(11):1243-1248.
Koizumi, Kiyoshi ; Arbab, Ali Syed ; Toyama, Keiji ; Shirasu, Masayo ; Osawa, Sachiko ; Araki, Takuji ; Yamaguchi, Motoshi ; Onishi, Hiroshi ; Araki, Tsutomu ; Arai, Takao ; Komatsu, Hideki ; Ueno, Akira ; Nokata, Hisashi. / 89Sr therapy for pain relief in patients with bone metastases. In: Kakuigaku. 1996 ; Vol. 33, No. 11. pp. 1243-1248.
@article{7d193c4d590c41a79ae99cc51537f550,
title = "89Sr therapy for pain relief in patients with bone metastases",
abstract = "Radioactive strontium chloride ( 89Sr) was administered for pain relief in 6 patients with bone metastases (4 prostate cancer and 2 breast cancer patients). Out of 6 patients, 2 showed apparent relief of bone pain and improvement of QOL, and 3 showed slight relief of the pain with or without improvement of QOL; that is, 83{\%} was effective. Side effects were seen in 2 patients; transient deterioration of bone pain in one patient and bone marrow suppression in the other patient. The patient who showed bone marrow suppression had rather more lesions of bone metastasis (diffuse metastasis) and least urinary excretion of the radioactivity. Urinary excretion for 2 days varied 5 to 40{\%} of the administered dose and was less in the patients with more metastatic lesions.",
keywords = "Bone metastasis, Pain relief, Radionuclide therapy, Sr",
author = "Kiyoshi Koizumi and Arbab, {Ali Syed} and Keiji Toyama and Masayo Shirasu and Sachiko Osawa and Takuji Araki and Motoshi Yamaguchi and Hiroshi Onishi and Tsutomu Araki and Takao Arai and Hideki Komatsu and Akira Ueno and Hisashi Nokata",
year = "1996",
month = "12",
day = "1",
language = "English (US)",
volume = "33",
pages = "1243--1248",
journal = "Kaku igaku. The Japanese journal of nuclear medicine",
issn = "0022-7854",
publisher = "Japanese Society of Nuclear Medicine",
number = "11",

}

TY - JOUR

T1 - 89Sr therapy for pain relief in patients with bone metastases

AU - Koizumi, Kiyoshi

AU - Arbab, Ali Syed

AU - Toyama, Keiji

AU - Shirasu, Masayo

AU - Osawa, Sachiko

AU - Araki, Takuji

AU - Yamaguchi, Motoshi

AU - Onishi, Hiroshi

AU - Araki, Tsutomu

AU - Arai, Takao

AU - Komatsu, Hideki

AU - Ueno, Akira

AU - Nokata, Hisashi

PY - 1996/12/1

Y1 - 1996/12/1

N2 - Radioactive strontium chloride ( 89Sr) was administered for pain relief in 6 patients with bone metastases (4 prostate cancer and 2 breast cancer patients). Out of 6 patients, 2 showed apparent relief of bone pain and improvement of QOL, and 3 showed slight relief of the pain with or without improvement of QOL; that is, 83% was effective. Side effects were seen in 2 patients; transient deterioration of bone pain in one patient and bone marrow suppression in the other patient. The patient who showed bone marrow suppression had rather more lesions of bone metastasis (diffuse metastasis) and least urinary excretion of the radioactivity. Urinary excretion for 2 days varied 5 to 40% of the administered dose and was less in the patients with more metastatic lesions.

AB - Radioactive strontium chloride ( 89Sr) was administered for pain relief in 6 patients with bone metastases (4 prostate cancer and 2 breast cancer patients). Out of 6 patients, 2 showed apparent relief of bone pain and improvement of QOL, and 3 showed slight relief of the pain with or without improvement of QOL; that is, 83% was effective. Side effects were seen in 2 patients; transient deterioration of bone pain in one patient and bone marrow suppression in the other patient. The patient who showed bone marrow suppression had rather more lesions of bone metastasis (diffuse metastasis) and least urinary excretion of the radioactivity. Urinary excretion for 2 days varied 5 to 40% of the administered dose and was less in the patients with more metastatic lesions.

KW - Bone metastasis

KW - Pain relief

KW - Radionuclide therapy

KW - Sr

UR - http://www.scopus.com/inward/record.url?scp=0030299789&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030299789&partnerID=8YFLogxK

M3 - Article

VL - 33

SP - 1243

EP - 1248

JO - Kaku igaku. The Japanese journal of nuclear medicine

JF - Kaku igaku. The Japanese journal of nuclear medicine

SN - 0022-7854

IS - 11

ER -